WHO ICTRP trial
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on…
PACTR202301655446404 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202301655446404 |
|---|---|
| Public title | A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients with Sickle Cell Disease who are at Increased Risk for Primary Stroke |
| Scientific title | A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients with Sickle Cell Disease who are at Increased Risk for Primary Stroke |
| Primary sponsor | Forma Therapeutics Inc |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase-2 |
| Countries | Nigeria;Nigeria;Nigeria |
| Conditions | Haematological Disorders;Haematological Disorders |
| Interventions | etavopivat;Etavopivat in combination with HU |
| Registration date | Nov 10, 2022 |
| Target size | 46 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: